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Diet, host gene composition, and alterations in the intestinal microbiota can contribute to obesity. Inmicrobe-
induced obesity, metabolic changes stem from primary perturbation of the microbiota, consequent to mod-
ern changes in human biology. Microbiota disruption during early development can result in syndromes of
metabolic dysfunction. We focus on the pathways involved in these interactions, particularly related to en-
ergy extraction and the role of inflammation in the metabolic phenotypes. Model physiologic systems and
perturbations including gastric bypass surgery, pregnancy, and hibernation provide insight into the respec-
tive roles of the critical participants.Introduction
In the late 20th century, obesity has markedly increased in the
U.S. (Flegal et al., 2012) as well as worldwide (Haslam and
James, 2005). Much focus on the origins of obesity has
centered on dietary excesses (diet-induced obesity [DIO]) or
on host genes (gene-induced obesity [GIO]) (Hollopeter et al.,
1998) (Figure 1). However, in addition to increased calories or
alterations in host metabolism, the composition of the intestinal
microbiota can contribute to the progression of obesity
(Ba¨ckhed et al., 2004; Turnbaugh et al., 2006, 2008); thus DIO
and GIO have both microbe-independent and microbe-depen-
dent mechanisms. Alternately, metabolic changes can stem
from a primary perturbation of the microbiota (Cho et al.,
2012), consequent to modern changes in human biology (Blaser
and Falkow, 2009; Dominguez-Bello et al., 2011) in which the
initiating factors lack microbe-independent effects (microbe-
induced obesity [MIO]). Epidemiological studies in humans
have shown that antibiotic treatment during the first 6 months
of life (Trasande et al., 2013), or disrupted colonization from
Caesarean section delivery (Blustein et al., 2013; Huh et al.,
2012), can increase the risk of being overweight later in life.
These two interventions have no direct contribution to host
caloric intake or metabolism (Coates et al., 1963) but have large
effects on the microbiome (Dethlefsen et al., 2008; Dominguez-
Bello et al., 2010).
The microbes that colonize humans substantially outnumber
human cells (Savage, 1977), and the collective unique microbial
genes outnumber human genes by a factor of more than 100
(Arumugam et al., 2011; Human Microbiome Project Con-
sortium, 2012; Qin et al., 2010). These coevolved microbes
have a complex role in maintaining health (Human Microbiome
Project Consortium, 2012) but can also contribute to disease
(Cho and Blaser, 2012; Holmes et al., 2012). Model systems
have been used to examine the effects of microbiome change
in the context of different diets or on early life development. In
this Perspective, we examine mechanistic pathways in which
the disrupted microbiome can contribute to obesity by altering
energy extraction from food or altering inflammation and immu-
nity (Figure 2). The microbiome is dynamic and resilient but sub-
ject to perturbations that can impact metabolism. We exploremajor recovery strategies in the microbiome in response to
host metabolic perturbations (Figure 3) and discuss metabolic
adaptations that aid particular classes of microbiota during re-
covery in the competitive environments of well-established eco-
systems (Figure 4).
Energy Extraction from Food
The diet provides nutrients to both the host and the microbial
consortium, which have coevolved to derive and impart benefits
to each other across a wide array of vertebrate lineages (Ley
et al., 2008a, 2008b). The microbiota improve the fitness of the
host by increasing resistance to pathogens, providing essential
vitamins, and increasing caloric extraction from food. The very
presence of microbiota influences weight gain and fat storage,
as germ-free mice have significantly lower weight and body fat
percent, despite eating more calories than conventionalized
mice (Ba¨ckhed et al., 2004).
Current technologies have allowed more efficient production
of food; consequently, the caloric intake has increased in both
men and women in the last 30 years (Wright et al., 2004).
Increased caloric intake for the host translates to increased en-
ergy availability for the microbiota, altering the environment
they inhabit (Kau et al., 2011). In addition, readily available pro-
cessed foods commonly substitute complex carbohydrates for
simple refined sugars and contain food preservatives, which
affect the composition and diversity of the microbiota (Bernbom
et al., 2006; Kau et al., 2011; Payne et al., 2012). In obesity, both
reduced microbial diversity and interconnectivity have been
observed (Greenblum et al., 2012; Turnbaugh et al., 2009),
consistent with our a priori notions of the importance of micro-
biota diversity to health.
An increase in caloric intake, whether from a high-fat diet (DIO)
(Turnbaugh et al., 2008) or from overeating normal chow driven
by the absence of the satiety hormone leptin in ob/ob mice
(GIO) (Turnbaugh et al., 2006), selects for obesogenic micro-
biota. This was demonstrated by transferring the obesity pheno-
type to germ-free recipient mice via microbiome transplantation,
providing evidence that, in addition to increased caloric con-
sumption, the microbiota can contribute to obesity (Figure 1).
Both DIO and ob/ob GIO caused phylum-level shifts in theCell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 883
Figure 1. Pathways in Microbe-Induced
Obesity
Normal physiological adaptations (i.e., preg-
nancy), genetic mutations or polymorphisms
(gene-induced obesity, GIO), or a diet with
excessive fat or calories (diet-induced obesity,
DIO) can promote weight gain and increase
adiposity through microbe-independent and
microbe-dependent mechanisms. Disrupting the
founding microbial community through Caesarean
section and/or early-life antibiotic exposure also
can lead to increased weight gain and adiposity
(microbe-induced obesity, MIO). The MIO effects
all are microbe dependent, since the initiating
factors do not contribute to obesity independent
of microbes (e.g., antibiotics have no caloric
value). For each pathway that leads to obesity, the
altered microbiota can contribute to adiposity
through increased energy harvest or by altering
metabolic signals, inflammation, or immunity.
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teroidetes (Ley et al., 2005, 2006; Turnbaugh et al., 2008). That
these broad phylum level changes have not been found consis-
tently (Ley, 2010; Ravussin et al., 2012) may indicate that the
important events involve lower taxonomic levels within these
phyla.
Dietary composition can alter the microbiota, independent of
the calories consumed. In a comparison of ad libitum-fed or
caloric-restricted mice receiving either a DIO diet or normal
chow, the dietary composition had a greater influence on
shaping the microbiota than caloric intake or host obesity status
(Ravussin et al., 2012). However, whether the metabolic pheno-
typewas transferrable to germ-free recipients was not assessed,
so it could not be determined whether the dietary composition or
the increased calories select for an obesogenic microbiota. That
excessive caloric intake in ob/ob mice receiving normal chow
and inmice fed ad libitumon aDIO diet selects for an obesogenic
microbiota argues that the increased caloric intake, not dietary
composition, is the driving force.
In the large intestine, complex nutrients that have not been ab-
sorbed by the host are fermented to short-chain fatty acids
(SCFAs), which contribute a small but significant number of cal-
ories to the host (Macfarlane and Macfarlane, 2012), estimated
to account for up to 10% of caloric intake in humans (Bergman,
1990) (Figure 2). SCFA also play a role in maintaining intestinal
health by acting as the major energy source for colonocytes
and having anti-cancer activity (Wong et al., 2006). The total pro-
duction of SCFAs, and thus calories contributed by microbiota,
depends on both dietary and microbiota composition. The ma-
jority of SCFAs are produced from carbohydrates, but a smaller
fraction can be produced from protein degradation, which yields
SCFAs plus other metabolic end products, such as amines, phe-
nols, thiols, and hydrogen sulfide (Macfarlane and Macfarlane,
2012). Leptin-deficient ob/ob mice harbor microbiota that pro-
duce more SCFA than wild-type (WT) mice and extract more cal-
ories from the diet (Turnbaugh et al., 2006). A similar increase in
microbial energy harvest was observed in lean humans switched
from consuming 2,400 to 3,400 calories per day (Jumpertz et al.,
2011). These findings show that in a GIOmurinemodel and a DIO
human simulation, the intestinal microbiota can adapt to an en-884 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.riched diet and contribute additional calories to the host
(Figure 1).
Metabolic disturbances can occur that are not caused by
either abnormal host gene status or dietary changes but instead
are driven by an aberrant microbiota (MIO). For example, the
microbiota may become altered as a result of an abnormal
founding population, as occurs with Caesarean section (Bia-
succi et al., 2010; Dominguez-Bello et al., 2010; Huurre et al.,
2008; Pandey et al., 2012). Epidemiologic studies indicate an
association of Caesarean section with the development of
childhood obesity (Blustein et al., 2013; Huh et al., 2012; Li
et al., 2013). Similarly, the microbiota can be altered by antibi-
otic exposure (Antonopoulos et al., 2009; Dethlefsen et al.,
2008; Ubeda and Pamer, 2012). In particular, antibiotic expo-
sure in early life, just when host adipocyte populations are
developing (Greenwood and Hirsch, 1974), has been associ-
ated with the development of adiposity in humans (Ajslev
et al., 2011; Trasande et al., 2013). In a murine model of MIO,
early life subtherapeutic antibiotic treatment (STAT) changed
microbiome composition and increased fat mass (Cho et al.,
2012). STAT increased the abundance of microbial genes
involved in SCFA production and also increased acetate, buty-
rate, and propionate concentrations in the intestine. Thus, if
SCFAs are markers of increased energy extraction, one driving
force behind MIO has been identified.
SCFAs also provide important microbial signals to the host,
in part via the G protein-coupled receptors GPR41 and
GPR43 (FFAR2 and FFAR1, respectively). The GPR41 receptor
on enteroendocrine cells senses SCFAs and induces secretion
of peptide YY (Ichimura et al., 2009), which both slows intesti-
nal transit time and increases satiety. Gpr41-deficient mice are
leaner than their WT counterparts (Table 1), due to decreased
PYY and increased intestinal transit rate (Samuel et al., 2008).
However, germ-free Gpr41/ mice exhibited no weight differ-
ences from germ-free WT mice, indicating that the effects are
dependent on the microbiota. Absorbed SCFAs also provide
metabolic signals to distant tissues. SCFAs bind GPR41 on ad-
ipocytes, increasing adipogenesis, inhibiting lipolysis, and
inducing leptin secretion (Ichimura et al., 2009). The major
product of microbial fermentation, acetate, is a substrate for
Figure 2. Pathways Involving Microbiome and Immunity that Contribute to Obesity
Undigested carbohydrates are fermented by the intestinal microbiota to short-chain fatty acids (SCFA), primarily acetate (60%), propionate (20%–25%), and
butyrate (15%–20%). SCFA can signal through G protein-coupled receptor 41 (GPR41) on enteroendocrine cells, inducing the secretion of peptide YY, which can
contribute to obesity by slowing transit time and thus increasing energy extraction from food, or can protect against obesity by increasing satiety. SCFA are
readily absorbed, contribute up to 10% of caloric intake, and can increase adipogenesis by binding GPR41 on adipocytes. In the liver, acetate is a substrate for
cholesterol synthesis and lipogenesis. Locally, butyrate increases the epithelial tight junctions, blocking the translocation of LPS, a potent inflammatory mediator
that increases weight gain, total body and liver adiposity, and insulin resistance. Similarly, the mucus layer can also block LPS translocation. Inflammasome
dysfunction allows translocation of bacterial products, which induce hepatic TNF-a expression and drive nonalcoholic steatohepatitis (NASH) in a TLR4/TLR9-
dependent manner in mice with other risk factors (e.g., methionine-choline-deficient diet). Loss of Tlr5, which senses bacterial flagellin, leads to a dysbiosis in the
microbiome, increased inflammatory cytokines, hyperphagia, insulin resistance, and diabetes in the context of a high-fat diet. The NASH andmetabolic syndrome
phenotypes in inflammasome- and Tlr5-deficient mice are transferrable via the microbiome to germ-free wild-type (WT) recipients, demonstrating the roles of the
altered microbiome in adiposity. (Inset) Deleting any component of the lymphotoxin pathway results in loss of control of the microbiome and blocks the ability of
mice to gain weight on high-fat diet. Cohousing lymphotoxin b receptor-deficient and WT mice restores diet-induced obesity and partially restores a WT/HFD
microbiota.
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2006). Early life STAT increased intestinal acetate as well as
the downstream (via the portal circulation) hepatic expression
of genes involved in fatty acid metabolism and lipogenesis
(Cho et al., 2012).
The extent of total energy extracted from the diet depends
on the structure of the intestinal tract, the composition of the
microbiota, and the composition of the diet. The dynamic
metabolic relationships can be understood by considering
continuous flow fermentation systems, in which the populationof microbes is maintained by balancing nutrient infusion and
waste removal. The evolution of a conserved and stable micro-
bial consortium requires overcoming a considerable set of
challenges. These concepts were first compiled by Hungate
in his classic work The Rumen and Its Microbes (Hungate,
1966). Because of the constant downward movement of
intestinal contents, a stable microbiota can only be achieved
if the net microbial growth equals the flow rate of the system.
Overnutrition can disrupt the microbial ecosystem and can
have severe consequences for both host and microbiota.Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 885
Table 1. Metabolic Consequences of Specified Host and Dietary Interactions with the Microbiome
Host State
Phenotype with
Microbiota
Phenotype in GF
Mice or with
Reduced Microbiotaa
Major Microbial
Changes Transferb References
ob/ [ Weight and adiposity Resistance to GIOa [ Firmicutes
Y Bacteroidetes
Yes Ley et al., 2005;
Turnbaugh et al., 2006;
Cani et al., 2008
High-calorie diet [ Weight and adiposity Resistance to DIO [ Firmicutes
Y Bacteroidetes
Yes Turnbaugh et al., 2008
Gpr41/ Lean No difference from
controls
Unknown Unknown Samuel et al., 2008
Pregnancy [ Weight and adiposity Unknown [ Lactic acid bacteria
Y Butyrate producers
Yes Koren et al., 2012
Tlr5/ Obese, insulin
resistant, hyperphagic
No difference from
controlsa
Changes at the OTU
level, no changes at
the phylum level
Yes Vijay-Kumar et al., 2010
Inflammasomes Asc/,
Casp1/,Nlp3/, IL18/
[ NASH No difference from
controlsa
[ Prevotellaceae and
Porphyromonadaceae
Yes Henao-Mejia et al., 2012
Lymphotoxin-deficientc
Ltbr/, Lta/, Ltb/
Resistant to DIO Unknown [ SFB and Cytophaga
Y Erysipelotrichi
Yes, but transient,
obese WT/ ltbr/
Upadhyay et al., 2012
Roux-en-Y gastric
bypass
Lean Unknown [ Gammaproteobacteria
[ Akkermansia
Yes Liou et al., 2013
aReduction in microbiota by high-dose broad-spectrum antibiotics.
bTransfer of the phenotype to conventional mice has been accomplished.
cResistance to DIO also achieved by deleting IL23a and RORgt, elements downstream of the lymphotoxin pathway.
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grass-based diet to a grain-based diet, the sudden influx of
starch in the digestive tract leads to an overgrowth of lactate-
producing Streptococcus bovis (Hungate et al., 1952). Lactic
acid accumulates in the rumen faster than can be utilized by
other ruminant microbes (Nagaraja and Titgemeyer, 2007).
The excess lactate decreases the pH of the rumen below 5,
resulting in acute systemic acidosis, which can lead to death
within 24 hr. This is an extreme example, since ruminants are
substantially different from mice and humans in the funda-
mental digestive tract organization. Ruminants are foregut
fermenters, while humans and mice are hindgut fermenters,
which may have evolved as an adaptation enabling wider vari-
ations in diet. For mice and humans, most of the microbiota
only receive nutrients after the host has extracted many of
the simple molecules, and thus hindgut fermenters are not
vulnerable to fatal indigestion from nutrient excess.
Major anatomical rearrangements of the gastrointestinal tract
of mice and humans produce large effects on energy extraction
and on the intestinal microbiota, in part due to changing factors
related to nutrient flux and pH (Aron-Wisnewsky et al., 2012). In
obese subjects undergoing Roux-en-Y gastric bypass (RYGB)
surgery, metabolic improvements can be observed in the first
week after the surgery, preceding significant weight loss (Ahn
et al., 2010; Rubino et al., 2004). These weight-independent
metabolic improvements may be mediated by rapid changes
in microbiota composition, since major reconstruction of the
gastrointestinal tract as part of gastric bypass significantly
alters the microbiota shortly after the surgery (Graessler et al.,
2012; Li et al., 2011). In a recent study by Liou et al., RYGB
had a more substantial effect on the microbiome than sham886 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.surgery or caloric restriction, even though mice receiving
caloric restriction also were significantly leaner than the
sham-surgery mice (Liou et al., 2013), demonstrating that gut
structure had greater impact on the microbiota than obesity
status. RYBG was associated with increased populations of
Proteobacteria (Escherichia) and Verrucomicrobia (Akkerman-
sia), and a reduction in Firmicutes compared to sham surgery
and weight restriction. Mice that underwent gastric bypass
extracted significantly less energy from the diet than mice
that underwent sham surgery or calorie-restricted mice, which
may have been mediated by a combination of gut restructuring
and changes in the intestinal microbiota. Germ-free mice colo-
nized with microbiota from RYGB mice weighed significantly
less than mice colonized with microbiota from sham surgery
mice, showing that the RYGB-altered microbiota play an
active role in weight loss and metabolic status. Both the
RYGB cecal donors and their recipient mice had decreased
total SCFA compared to sham donors and recipients, with
major reductions in acetate levels and a relative increase in
propionate levels, providing further evidence that SCFAs influ-
ence obesity.
Inflammation and Immunity
The interaction between diet, genes, and the intestinal micro-
biota in the context of obesity is complex (Parks et al., 2013),
since each of these factors has the potential to modulate
inflammation and immunity (Kau et al., 2011). Obesity is
a low-grade inflammatory disorder, and the role of the micro-
biota via specific immune pathways has been studied with
the aid of experiments involving germ-free and knockout mice
(Table 1).
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High-fat diet (HFD) can increase absorption of lipopolysac-
charide (LPS), a component of gram-negative bacterial cell
walls, either by incorporation into chylomicrons or by
increasing intestinal permeability (Cani et al., 2007, 2008).
LPS is a potent inflammatory mediator that signals in a
CD14/TLR4-dependent manner, and infusion of LPS alone
can increase weight gain, adiposity, insulin resistance, and
liver triglycerides similar to a HFD. High-dose antibiotic treat-
ment or deletion of CD14 reduces inflammatory cytokine
expression and ameliorates weight gain on HFD, demon-
strating the important interaction of microbiota and inflamma-
tory signaling cascades. Prebiotic fibers fermented to SCFA by
the intestinal microbiota can block LPS-mediated metabolic
consequences by increasing colonic expression of tight junc-
tion proteins zona occludens 1 and claudin 3, improving gut
barrier function and reducing systemic LPS (Neyrinck et al.,
2012) (Figure 2).
Akkermansia muciniphila, amicrobial specialist that can derive
its carbon and energy sources from mucus lining the intestinal
tract, increases with prebiotic treatment (Everard et al., 2011).
In addition to the metabolic and inflammatory changes previ-
ously discussed, HFD reduces A. muciniphila levels and thins
the mucus layer (Everard et al., 2013). Introduction of
A. muciniphila by daily oral gavage to mice fed HFD restores
the mucus layer, decreases circulating LPS levels, decreases
fat mass gain, and increases glucose tolerance compared to
mice gavaged with PBS. These changes in metabolism and
inflammation were not produced by killed A. muciniphila or by
the ‘‘probiotic’’ strain Lactobacillus plantarum, indicating that
live A. muciniphila has specialist actions that improve the gut
barrier and reduce the effects of DIO.
TLR5
Deletion of the innate immunity receptor Tlr5, which senses
bacterial flagellin, induces inflammation, which if mild causes
a metabolic syndrome including hyperphagia-dependent
weight gain; insulin resistance; and increased adiposity, blood
pressure, and cholesterolemia (Vijay-Kumar et al., 2010). These
changes were linked with increased adipocyte proinflammatory
cytokines IL-1b and INF-g. An antibiotic regimen that reduced
microbial density 100-fold abrogated the metabolic syndrome
in Tlr5/ mice, and conversely, germ-free mice that were colo-
nized with Tlr5/ microbiota showed many of the disease phe-
notypes. Together these results indicate the sufficiency of the
altered microbiota to yield the pathologies that accompany
Tlr5 deficiency. However, some Tlr5/ mice have an opposing
phenotype of severe colitis leading to weight loss, not gain
(Vijay-Kumar et al., 2007). In a separate study, Tlr5/ mice
housed at two different animal facilities did not show an obesity
phenotype or increased basal intestinal inflammation (Letran
et al., 2011). The circulating microbes in separate facilities
can lead to animals with differential microbiota colonization,
altering host immune phenotypes (Ivanov et al., 2009). Since
the genetic background was the same for the Tlr5/ mice,
the local microbiota in each animal facility most likely
accounted for differences in the immune and metabolic pheno-
types. Thus, in this model, the colonizing microbiota character-
istics might determine inflammation extent and which pathway
dominates.Lymphotoxin Mediates Diet-Induced Obesity through
the Microbiota
Lymphotoxin, secreted by Th1 lymphocytes and implicated in
obesity by GWAS, is involved in the control of mucosal intesti-
nal microbiota (Upadhyay et al., 2012). Lymphotoxin b recep-
tor-deficient (Ltbr/) mice have reduced colonic IL-22 and
RegIII antimicrobial peptide expression and elevated levels of
segmented filamentous bacteria (SFB), consistent with dimin-
ished immune control at the mucosal surface (Upadhyay
et al., 2012). Addition of HFD further shifts both immune re-
sponses and metabolism, including increasing colonic IL-23
expression, weight, and adiposity. When any of the compo-
nents in the axis are eliminated, including HFD, lymphotoxin
a or b subunits, lymphotoxin b receptor (Ltbr/), IL-23, or
RORgt (Th17) cells, mice become DIO resistant (Figure 2,
inset). The dietary changes and the differences in Ltbr status
account for 52% and 18% of the variation in the microbiome,
respectively. Several expected microbiome shifts associated
with introduction of a HFD, such as an increase in Firmicutes
and a loss in diversity, were only observed in Ltbr+/ mice,
but not in Ltbr/ mice. GF WT mice conventionalized with
microbiota from HFD-fed Ltbr/ mice transiently resist DIO,
but the phenotype gradually reverts, due to their (WT) immune
development. When HFD-fed Ltbr/ mice are cohoused with
DIO-susceptible Ltbr+/ mice, the Ltbr/ mice gain more
weight, indicating the dominance of the transferred microbiota
selected by HFD in the presence of a functional lymphotoxin
pathway.
Inflammasomes and NASH
Multiprotein complexes that sense pathogen-associated mo-
lecular patterns (PAMPs), known as inflammasomes, aid in
mucosal defenses by activating the inflammatory cytokine pre-
cursors pro-IL-1b and pro-IL-18. Inflammasomes have been
implicated in the progression from nonalcoholic fatty liver dis-
ease to nonalcoholic steatohepatitis (NASH) (Henao-Mejia
et al., 2012). Apoptosis-associated speck-like protein contain-
ing a CARD (ASC) is a key adaptor protein of the inflamma-
some complex. Asc-deficient mice show higher levels of
TLR4 and TLR9 agonists in the portal circulation and higher
hepatic TNF-a expression than WT mice, indicating that micro-
bial products translocate to the liver and induce inflammation.
When given a methionine-choline-deficient diet known to
induce NASH, mice lacking Asc or other components of the in-
flammasome complex (caspase-1, NLRP3) or downstream
signaling (IL-18/) develop NASH at a higher incidence than
WT mice. The enhanced NASH phenotype in Asc/ mice
was ablated with deletion of either Tlr4, Tlr9, MyD88:Trif, or
TNF-a, demonstrating the importance of innate immune path-
ways. However, the presence of the intestinal microbiota is
also necessary because high-dose broad-spectrum antibiotics
in Asc/ mice reduce NASH incidence. When WT mice were
cohoused with Asc/ mice, WT mice developed NASH more
frequently, which was associated with increased Prevotella-
ceae, showing the importance of the altered microbiome in dis-
ease risk.
All told, these models of DIO and GIO illustrate the
importance of immune control of intestinal microbiota, whose
relaxation or activation can result in pathologic metabolic conse-
quences.Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 887
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Systems Approaches
There are long-standing immunologic and metabolic relation-
ships between the host and microbiota, and there can be
consequences following natural and artificial perturbations. Mi-
crobial diversity and stability are important when considering
the complex intracommunity interactions that lead to emergent
properties of the system. Well-evolved ecosystems often have
functional redundancy in which several species can perform
the same task. This concept explains how the taxa that consti-
tute the mammalian gut microbiome often are highly diverse
and variable from person to person, yet share high-degree func-
tional capacity (Human Microbiome Project Consortium, 2012;
Kurokawa et al., 2007; Turnbaugh et al., 2009). However, eco-
systems can be disrupted. In the case of forests, it might be fires,
landslides, or droughts (Paine et al., 1998). For human micro-
biota, it might be famine, surfeit, antibiotic treatments, or even
parturition. Each of these events has the potential to change
the energy flow in tightly regulated systems, and consequences,
including loss in diversity, vary according to the system’s status
and the extent of functional redundancy. As diversity declines,
loss of function may not be immediately apparent until the last
redundant member able to perform a function is gone; however,
communities with lower diversity are less resilient when subject
to further perturbations (Kau et al., 2011). For perturbations of
host-associated microbiota, timing is important, because the
effects and their consequences may differ according to stage
of life.
Despite the obvious differences in geography, diet, and life-
style, there are strong similarities in the age-specific features
of the microbial composition in persons living in the United
States, Malawi, and Venezuela (Yatsunenko et al., 2012).
Regardless of origin, babies begin life with low diversity, which
progressively increases over the first years of life, and for all,
the outline of the adult microbiome is essentially established
by the age of three. Unsurprisingly, considering the long-stand-
ing differences in diet reflected in the three populations, the
biochemical pathways represented in the metagenomes varied
substantially. The study subjects differed substantially in the
overall diversity in adulthood: the average adult in the U.S.
had from 225 to 400 fewer operational taxonomic units
(OTUs) (or approximately 15%–25% fewer) than did the Mala-
wians or Venezuelan Amerindians. This observation is consis-
tent with our earlier hypothesis of a ‘‘disappearing microbiota’’
due to the changes represented by modernity (Blaser and
Falkow, 2009), and may be the harbinger of functional losses
as well.
Pregnancy
Parturition is amajor biological perturbation, yet is a critical event
in the animal life cycle. The energetics are complex, since the
needs of the mother and her offspring must be balanced, and
in mammals the mother’s role extends far beyond birth. Nature’s
challenge is to provide a sufficient endowment to the next gen-
eration while safeguarding the mother’s own health for the
essential tasks ahead. Multiple adaptations in the maternal im-
mune system allow tolerance of the growing fetus (Erlebacher,
2013; Thellin and Heinen, 2003). The GI microbiota composition
shifts remarkably over the course of pregnancy and continuing
beyond (Koren et al., 2012). Its progressive nature implies that888 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.an optimum exists, timed to the events of parturition and consis-
tent with a model of balanced outcome.
There are temporal shifts in both the diversity within a single
microbial community, known as a-diversity, which can be
measured by phylogenetic diversity, species richness, and
Shannon’s index, and in the diversity shared among different
communities, known as b-diversity, which, for example, can be
measured by UniFrac distances, changes in microbial abun-
dance, and the Jaccard index (Lozupone and Knight, 2008).
The microbiota in late pregnancy has reduced a-diversity but
higher b-diversity compared to nonpregnant women or early
pregnancy (Koren et al., 2012). In the third trimester, there is
greater representation of lactic acid bacteria (Lactobacillus,
Streptococcus, and Enterococcus), which are highly prevalent
in the infant gut, whereas butyrate-producing bacteria
(Faecalibacterium, Blautia, and Ruminococcus), which dominate
the gut in adulthood, are enriched in early pregnancy. Since
mammals have evolved to provide a portion of their microbes
to their offspring, shifts occurring during pregnancy may reflect
selection that increases the probability of offspring survival.
The greater representation of lactic acid bacteria may be seen
as an adaptation to prepare the mother for transfer of these or-
ganisms in the birth and perinatal period to her offspring to
take maximum advantage of the main energy source for the
child, lactose in its mother’s milk. The increased b-diversity re-
flects the variation in the different pathways by which nature ac-
complishes its goals of intergenerational transfer.
When germ-free mice were conventionalized with fecal micro-
biota from women in their first (T1) or third (T3) trimester of
pregnancy, those receiving the T3 microbiota had increased
intestinal cytokines, gained more weight, and were more
glucose intolerant than those receiving the T1 microbiota. This
result implies that the T3 microbiota induces an alternative
metabolic state in its host, associated with greater energy
storage. The findings in mice mimic those in pregnant women
who also gain weight and develop insulin resistance, but vary
in the degree of these phenotypes. The trimester-specific differ-
ences provide evidence for a microbiota-driven energy optimum
to maximize maternal fitness and caloric transfer to the next
generation. This concept is consistent with the notion of a
coevolved microbiota that optimizes host survival through
effects on its progeny.
Perturbation
Perturbation, an important constraint in biological systems, may
be random, episodic, or programmed, like pregnancy or hiberna-
tion. Well-evolved ecosystems have long histories of perturba-
tion, in part documented by and captured within their existing
population structure (Paine et al., 1998). Ecosystem stability re-
flects both its resistance to change and its resilience following
perturbation (Costello et al., 2012; Shade et al., 2012). Changes
in diet in omnivorous hosts substantially perturb the gut micro-
biome (e.g., adding high fat [Turnbaugh et al., 2008], fiber [Cox
et al., 2013], and protein [Faith et al., 2011]), and changes in
the mode of birth delivery are associated with alterations in the
patterns established for vertical microbiome transmission,
comparing vaginal delivery and Caesarean sections (Domi-
nguez-Bello et al., 2010). Direct exposure to antibacterial agents
has the greatest potential for perturbation and occurs frequently
in the U.S. Based on recent CDC data (Hicks et al., 2013), more
Figure 3. Response of r- and K-Selected Species to Environmental Stress
(A) r-species recover from environmental stress optimizing growth rate and productivity, while K-selected species resist environmental change by optimizing their
efficiency when resources are scarce.
(B) Following a large and sudden perturbation in which both r- and K-selected species suffer diminished in population levels, the r-selected species can rapidly
bloom and dominate the environment due to utilization of unused resources, whereas the recovery from K-selected species is slower. During a longer, sustained
environmental stress, K-selected species can resist large population losses because of their high-efficiency adaptation strategies, whereas r-selected species
are more constrained to maintain populations, and therefore suffer losses.
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in 2010, which represents 880 courses of antibiotics per 1,000
population. Short antibiotic courses in adults cause profound
but incompletely understood changes in community structure,
with variable resilience (Dethlefsen et al., 2008). Perturbation
during early life, when the gut community structure is emerging
(Yatsunenko et al., 2012), may be most important, since it is
occurring during a developmentally sensitive host window (Cho
et al., 2012). The CDC data indicate that the average child in
the U.S. is receiving about three antibiotic courses in first 2 years
of life and nearly 11 courses by age 10 (Hicks et al., 2013). To un-
derstand the impact of these perturbations, ecological theory
can guide us through the ground rules governing ecosystem re-
sponses.
Within ecosystems, there are r- or K-selected species, which
have evolved alternate strategies to cope with environmental
disruption (Reznick et al., 2002). r-selected species evolved to
have a rapid growth rate to monopolize resources when compe-
tition is low following a large ecological disruption, whereas
K-selected species have evolved for efficiency to persist when
the carrying capacity of the environment is low (Figure 3). In
the intestine, large perturbations can result from antibiotic expo-
sure, extreme changes in diet, surgical interventions, and acute
gastrointestinal illnesses. Carrying capacity can be limited by
availability of nutrients, electron acceptors (e.g., oxygen), or
even physical niches. Aweed is an example of an r-selected spe-
cies with high proliferative potential. Weeds often are normal
members of the ecosystem that live at the fringe in microhabi-
tats, since competitors lock up the necessary resources for its
expansion, but after a large perturbation, weeds can grow out
of control. Whether native or introduced, the r-selected weeds
are usually considered as invaders because of their unbalanced
residency in the environment. Members of the phylum Proteo-
bacteria or Verrucomicrobia usually represent a minor popula-
tion within the intestinal microbiome but can dominate following
antibiotic therapy (Dubourg et al., 2013; Ubeda and Pamer,
2012), gastric bypass (Graessler et al., 2012; Liou et al., 2013),
or dietary shifts (Parks et al., 2013), and thus may be examplesof r-selected species dominating an environment following a
perturbation. The gradual shift from facultative anaerobic bacte-
ria (Proteobacteria and Bacilli) to strict anaerobes (Bacteroidia,
Clostridia, and Erysipelotrichi) in the developing infant gut (Pan-
toja-Feliciano et al., 2013)may be driven by a competitive advan-
tage of the K-species strict anaerobes to maintain populations
when oxygen is limited.
After an ecosystem is perturbed, exogenous organisms are
more likely to successfully invade. Recovery from perturbation
requires a full complement of species or of functional groups.
In the gut, there appears to be enormous functional redundancy
(Human Microbiome Project Consortium, 2012; Turnbaugh
et al., 2009). However, there could be keystone species, defined
as those that have disproportional influence on the behavior
of the system as a whole, that when lost or gained have a pro-
found influence on health. For example, on the plains, wolves
have a very small population footprint, but their predatory pres-
ence affects much larger communities of grazers, and even
larger populations of plants that the grazers eat. An important
consequence of perturbations is loss of keystone species, in
which small populations can oscillate down to zero and thus
are lost.
Very successful organisms, whether they are r- or K-selected,
often have bistable states. Bistability is an ancient adaptation to
long-term niches that are subject to significant and frequent per-
turbations. Unpredictable food supplies, which constrain most
animal populations, are an example of a typical perturbation.
The alternative forms in bistable states allow optimization in
changing milieus. When conditions change, rapid growers like
Clostridium species can form spores to transmit to the next
susceptible host. At the cost of not adding to the population of
proliferating cells that stably colonize a given host, exchanging
metabolic signals with the host and/or other microbiota,
Clostridium sp. diverts its metabolism to the spore form that is
most likely to survive transmission. There is fitness cost in divert-
ing energy to formation of the seeds that spores represent, but
there also is great fitness value, since host life span is finite.
Such dynamics affect the partitioning of energy in the gut lumen,Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 889
Figure 4. Microbial Equilibrium and Host
Effects in Relation to Energy Substrates
Microbes in the intestine can derive energy from
the diet, the host, or compounds secreted by other
members of the consortium. Four classes of mi-
crobes may be considered, based on their pre-
dominant energy source: diet (purple), host
(green), either diet or host (pink), or neither diet nor
host (orange). Competition for niche colonization
is affected by differential growth rates (r- and K-
selected species), utilization of exclusive sub-
strates, susceptibility to host defenses (e.g., anti-
microbial peptides), production of inhibitory
products, and community organization (e.g., au-
toinducers). Perturbation may occur, for example,
via dietary change (e.g., changes in a micro- or
macronutrient or long-term fasting), by antibiotics
that differentially select themicrobiota, or changes
in gastrointestinal tract structure (e.g., gastric
bypass). Importantly, in this model, competition
between the major classes affects host mucus
layer, epithelial permeability, and inflammation,
which has downstream metabolic consequences.
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their animal hosts, bacteria have the ability to bloom on a very
short timescale with logarithmic expansion of their share of the
energy pie, ultimately affecting transmission at critical junctures.
This characteristic is a factor, intrinsic to any well-evolved ecol-
ogy, subject to competition by other organisms operating with
parallel strategies, and to host constraints, which are obligatorily
obeyed.
Energy Source and Perturbation: The Case of
Hibernation
Throughout the biosphere, there is vigorous competition for en-
ergy. In well-evolved mature stable ecosystems, carbon meta-
bolism is tightly regulated (Mackelprang et al., 2011), implying
that checks exist against one species gaining a disproportionate
share of the available nutrients. Hibernation is a massive physio-
logical shift that is programmed that affects both central meta-
bolism and the immune system (Bouma et al., 2010; Carey
et al., 2003; Humphries et al., 2003). That energy storage and
utilization are central to hibernation physiology provides an
excellent model system to examine microbial characteristics
associated with an annual perturbation cycle. Some colonizers
of the mammalian colon have the ability to obtain their energy
not from the food substrate passing through the intestine, but
rather from digesting host-derived molecules (Berry et al.,890 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.2013). One important example is Akker-
mansia muciniphila, a member of the Ver-
rucomicrobia phylum, which can use
mucin as its sole carbon and nitrogen
source (Derrien et al., 2004). That Akker-
mansia utilizes mucins for energy, which
are virtually unlimited in supply in the
vertebrate gut, represents an apparent
paradox. With a readily available and
apparently inexhaustible relatively exclu-
sive food supply, why are Verrucomicro-
bia not always the dominant organism in
the gut ecosystem? Similarly, what are
the consequences to the host of an or-ganism that has the ability to deplete its mucus, an important
component of its barrier against potentially pathogenic micro-
biota and their toxic products?
Verrucomicrobia abundance is not constant in the intestinal
microbiota; proportions increase with disruption and dysbiosis,
e.g., antibiotic treatment (Dubourg et al., 2013), or increase
with an influx of fermentable fiber (Tachon et al., 2013). The
change in microbiota in hibernating ground squirrels provides
an excellent paradigm (Carey et al., 2013) with broad implica-
tions. Squirrels store energy in the summer and hibernate
in the winter. In the late winter, essentially all of the energy avail-
able to the microbiota is host derived. Hibernation, rather than
specific host, diet, or age, is the major determinant of the gut mi-
crobial community composition. During the seasons of feeding,
Firmicutes, which are specialists in dietary carbohydrates (Flint
et al., 2012), dominate, but after several months of fasting, their
representation falls, replaced by Verrucomicrobia, as well as by
bacteroidetes, which can switch their expression of genes
related to diet- or host-related energy sources (Martens et al.,
2008; Salyers et al., 1977).
This programmed seasonal restructuring in relation to hiberna-
tion and its consequent dietary limitation is useful to model the
energy relationships between themajor gutmicrobiota taxa clas-
ses and the effects on host pathophysiology (Figure 4). In a
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bernators), the populations of (r-selected) organisms that utilize
host-derived substrates are held in check by competing organ-
isms that use the plentiful dietary food sources. Change in the
mucus layer is minimized. Dietary utilizers also break down
complex macronutrients into small monomers or ferment
them to SCFA, which are required nutrients for other microbial
consortia. Use of SCFA by these transactional species is a
benefit to dietary utilizers because it is removing a waste prod-
uct that could detrimentally lower pH. However, in perturbed
states (and in times of fasting for hibernators), the organisms
that use dietary sources are disrupted and fail to check the
growth of the host substrate users or to provide crossfeeding
metabolites. The resulting overgrowth of organisms that
utilize host substrates depletes the mucus layer and
diminishes its barrier function. Similarly, butyrate, produced
by fermentation of dietary carbohydrates, and known to
enhance tight junctions (Wong et al., 2006), is reduced during
fasting. These changes are manifested as an increase in the
cellularity of the lamina propria and a reduction in villus length
(Kurtz and Carey, 2007). To the pathologist, this would be ‘‘co-
litis,’’ except that in the hibernator it is the physiologic conse-
quence of its lifestyle. The digestion of mucus and the loss of
butyrate resulting from perturbations that affect the microbes
requiring dietary energy sources are examples of secondary ef-
fects on the interface between the microbiota and the host.
These can result in differential signaling to epithelial and im-
mune cells, with both immune and metabolic consequences
(Canani et al., 2011).
The dynamics of the interactions suggest that there are
boundary conditions that govern the microbial population
structure in each gut locality. However, in total, the con-
served nature of the relationships of the major phyla to
one another, and their fluctuation with perturbation, suggests
the operation of a Nash equilibrium (Blaser and Kirschner,
2007), a game theory construct in which good behavior by
players is rewarded and ‘‘cheaters’’ achieve inferior results
(Nash, 1951). Within the boundary conditions of the gut, with
competing organisms and alternative energy substrates
that affect host viability, the development of a Nash equilib-
rium can explain the conserved dynamic changes observed
between the microbe phyla and the host. The overall con-
servation of the mammalian colonic microbial community
structure is an important observation that indicates shared
solutions between hosts and their resident microbes that
have persisted for >50 million years of evolution (Ley et al.,
2008a). This timescale implies that important boundary con-
ditions have selected against marked divergence from a com-
mon ancestry. In contrast, the presence of alternative macro-
level population structures in mammals (Arumugam et al.,
2011) could be a condition inconsistent with a conserved
Nash equilibrium.
Conclusions
Host phenotypes in obesity are dependent on the interac-
tions between the diet, the resident microbiota, and host
immunity. Evolutionary and ecological theories ultimately
govern, but the principal actors include the differential micro-
bial energetics and the host cells that monitor the microbialdenizens. We are just beginning to explore a complex and
ultimately crucial biological system, all the more important
because it appears to be changing out of proportion to evolu-
tionary time.REFERENCES
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